Bell RL - Search Results

1

Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors.

Kolasa T, Brooks CD, Rodriques KE, Summers JB, Dellaria JF, Hulkower KI, Bouska J, Bell RL, Carter GW. Kolasa T, et al. Among authors: bell rl. J Med Chem. 1997 Feb 28;40(5):819-24. doi: 10.1021/jm9606150. J Med Chem. 1997. PMID: 9057869

2

The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.

Bell RL, Young PR, Albert D, Lanni C, Summers JB, Brooks DW, Rubin P, Carter GW. Bell RL, et al. Int J Immunopharmacol. 1992 Apr;14(3):505-10. doi: 10.1016/0192-0561(92)90182-k. Int J Immunopharmacol. 1992. PMID: 1618602 Review.

3

5-lipoxygenase inhibitory activity of zileuton.

Carter GW, Young PR, Albert DH, Bouska J, Dyer R, Bell RL, Summers JB, Brooks DW. Carter GW, et al. Among authors: bell rl. J Pharmacol Exp Ther. 1991 Mar;256(3):929-37. J Pharmacol Exp Ther. 1991. PMID: 1848634

4

4-hydroxythiazole inhibitors of 5-lipoxygenase.

Kerdesky FA, Holms JH, Moore JL, Bell RL, Dyer RD, Carter GW, Brooks DW. Kerdesky FA, et al. Among authors: bell rl. J Med Chem. 1991 Jul;34(7):2158-65. doi: 10.1021/jm00111a035. J Med Chem. 1991. PMID: 2066989

5

Stereoselective metabolism of the 5-lipoxygenase inhibitor A-78773.

Carter GW, Bell RL, Marsh K, Lanni C, Awni WM, Bouska J, Stewart AO, Hansen R, Dubé L, Brooks DW. Carter GW, et al. Among authors: bell rl. Ann N Y Acad Sci. 1994 Nov 15;744:262-73. doi: 10.1111/j.1749-6632.1994.tb52744.x. Ann N Y Acad Sci. 1994. PMID: 7825849

6

Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.

Bell RL, Bouska JB, Malo PE, Lanni C, Harris RR, Otis ER, Stewart AO, Brooks DW, Carter GW. Bell RL, et al. J Pharmacol Exp Ther. 1995 Feb;272(2):724-31. J Pharmacol Exp Ther. 1995. PMID: 7853186

7

The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis.

Malo PE, Bell RL, Shaughnessy TK, Summers JB, Brooks DW, Carter GW. Malo PE, et al. Among authors: bell rl. Pulm Pharmacol. 1994 Apr;7(2):73-9. doi: 10.1006/pulp.1994.1008. Pulm Pharmacol. 1994. PMID: 8081074

8

The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor.

Bell RL, Bouska J, Young PR, Lanni C, Machinist J, Malo PE, Summers JB, Brooks DW, Carter GW. Bell RL, et al. Agents Actions. 1993 Mar;38(3-4):178-87. doi: 10.1007/BF01976209. Agents Actions. 1993. PMID: 8213344

9

5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.

Bhatia PA, Brooks CD, Basha A, Ratajczyk JD, Gunn BP, Bouska JB, Lanni C, Young PR, Bell RL, Carter GW. Bhatia PA, et al. Among authors: bell rl. J Med Chem. 1996 Sep 27;39(20):3938-50. doi: 10.1021/jm960372b. J Med Chem. 1996. PMID: 8831760

10

Conversion of cyclooxygenase inhibitors into hydroxythiazole 5-lipoxygenase inhibitors.

Kerdesky FA, Brooks CD, Hulkower KI, Bouska JB, Bell RL. Kerdesky FA, et al. Among authors: bell rl. Bioorg Med Chem. 1997 Feb;5(2):393-6. doi: 10.1016/s0968-0896(96)00255-6. Bioorg Med Chem. 1997. PMID: 9061203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters